Plain-English translation of NCT05613413 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether two medications— and —work well together as a long-term treatment for advanced squamous non-small cell lung cancer. You would first receive four cycles of initial chemotherapy combined with . If your cancer stops growing or shrinks, you would then continue with the medication combination to try to keep your cancer under control.
Most people with advanced squamous lung cancer need ongoing treatment after their initial chemotherapy to prevent the cancer from coming back. Researchers want to see if this medication combination can help keep the cancer controlled longer and improve survival.
You likely qualify if…
You likely don't qualify if…
You would first complete four cycles of initial chemotherapy combined with given at your cancer center. If your cancer responds well (stops growing or shrinks), you would then continue on the maintenance phase, taking the two-medication combination for as long as it continues to help control your cancer or until side effects become too difficult. Throughout the trial, you would have regular clinic visits, blood tests, imaging scans to monitor your cancer, and questionnaires about how the treatment is affecting your quality of life.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
United States